Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $21.81, but opened at $22.99. Privia Health Group shares last traded at $23.13, with a volume of 68,364 shares.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on PRVA. Piper Sandler decreased their target price on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a research note on Monday, August 11th. Barclays upped their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a report on Tuesday, May 27th. Evercore ISI decreased their price objective on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. JPMorgan Chase & Co. increased their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 28th. Finally, Citigroup reissued an "outperform" rating on shares of Privia Health Group in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Privia Health Group presently has a consensus rating of "Moderate Buy" and an average price target of $28.08.
Read Our Latest Analysis on PRVA
Privia Health Group Stock Up 5.6%
The business has a 50-day moving average price of $20.91 and a two-hundred day moving average price of $22.63. The firm has a market cap of $2.83 billion, a PE ratio of 209.46, a price-to-earnings-growth ratio of 3.37 and a beta of 0.82.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The company had revenue of $521.15 million for the quarter, compared to analysts' expectations of $466.97 million. During the same period in the prior year, the company posted $0.19 EPS. The firm's revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.
Institutional Trading of Privia Health Group
A number of large investors have recently modified their holdings of the stock. US Bancorp DE increased its position in shares of Privia Health Group by 2.4% during the first quarter. US Bancorp DE now owns 18,487 shares of the company's stock worth $415,000 after acquiring an additional 429 shares during the period. Park Avenue Securities LLC grew its stake in shares of Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock worth $342,000 after purchasing an additional 532 shares in the last quarter. Bank of Montreal Can grew its stake in shares of Privia Health Group by 1.9% during the second quarter. Bank of Montreal Can now owns 28,694 shares of the company's stock worth $660,000 after purchasing an additional 543 shares in the last quarter. CWM LLC grew its stake in shares of Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after purchasing an additional 604 shares in the last quarter. Finally, Financial Management Professionals Inc. grew its stake in shares of Privia Health Group by 28.7% during the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock worth $76,000 after purchasing an additional 754 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.
Privia Health Group Company Profile
(
Get Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Stories
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
